journal article·2023-09-11

Sensitive Detection of Tumor Cells Using Protein Nanoparticles with Multiple Displays of DNA Aptamers and Bioluminescent Reporters

Kei Nishida, Gaoyang Wang, Eiry Kobatake, Masayasu Mie

Publisher page

Abstract

Simple and effective detection methods for circulating tumor cells are essential for early detection and progression monitoring of tumors. The use of DNA aptamer and bioluminescence is expected to be a key tool for the simple, effective, and sensitive detection of tumor cells. Herein, we designed multifunctional protein nanoparticles for the detection of tumor cells using DNA aptamer and bioluminescence. Fusion proteins (ELP-poly(d)-POIs), composed of elastin-like polypeptide (ELP) fused with protein of interests (POIs) via poly(aspartic acid) (poly(d)), formed the protein nanoparticles based on the temperature responsivity of ELP sequences, leading to multiply displayed POIs on the protein nanoparticles. In the present study, we focused on porcine circovirus type 2 replication initiation protein (Rep), which covalently conjugated with DNA aptamers, and NanoLuc luciferase (Nluc), which emitted a strong bioluminescence, as POIs. ELP-poly(d)-Rep and ELP-poly(d)-Nluc were constructed and formed the protein nanoparticles with multiply displayed Nluc and Rep (DNA aptamer) that amplified the bioluminescence signal and tumor recognition ability. Mucin-1 (MUC1)-overexpressing human breast tumor MCF7 cells and MUC1-recognizing aptamer (MUC1 aptamer) were selected as models. The MUC1 aptamer-conjugated protein nanoparticles exhibited a 13.7-fold higher bioluminescence signal to MCF-7 cells than to human embryonic kidney 293 (HEK293) cells, which express low levels of MUC1. Furthermore, the protein nanoparticles could detect up to 70.7 cells/mL of MCF-7 cells from a cell suspension containing HEK-293. The protein nanoparticles with multiple Rep and Nluc show a great potential as a material for detecting CTCs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Bacteriophages and microbial interactions · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8502, Japan

Funding

Japan Agency for Medical Research and Development · Japan Society for the Promotion of Science · Fukuoka Public Health Promotion Organization Cancer Research Fund · Terumo Life Science Foundation

References (48)

Show source-provided references
1. 10.1158/1078-0432.CCR-08-087210.1158/1078-0432.CCR-08-0872 ↗
2. 10.1039/c9tb01490j10.1039/c9tb01490j ↗
3. 10.3389/fgene.2019.0095810.3389/fgene.2019.00958 ↗
4. 10.1016/j.molonc.2015.12.00210.1016/j.molonc.2015.12.002 ↗
5. 10.1007/s11605-017-3619-310.1007/s11605-017-3619-3 ↗
6. 10.1002/smll.20160139410.1002/smll.201601394 ↗
7. 10.3390/ijms22231307310.3390/ijms222313073 ↗
8. 10.1177/221106821349439110.1177/2211068213494391 ↗
9. 10.1038/nmeth.340410.1038/nmeth.3404 ↗
10. 10.1038/srep1227010.1038/srep12270 ↗
11. 10.1002/smll.20140071910.1002/smll.201400719 ↗
12. 10.1002/cam4.379010.1002/cam4.3790 ↗
13. 10.1186/1471-2407-12-20610.1186/1471-2407-12-206 ↗
14. 10.1073/pnas.070387510410.1073/pnas.0703875104 ↗
15. 10.1021/acs.analchem.1c0478710.1021/acs.analchem.1c04787 ↗
16. 10.1021/ac400193b10.1021/ac400193b ↗
17. 10.1172/JCI3860910.1172/JCI38609 ↗
18. 10.1016/j.nantod.2020.10094310.1016/j.nantod.2020.100943 ↗
19. 10.1021/acsami.0c1239510.1021/acsami.0c12395 ↗
20. 10.1016/j.biopha.2018.02.06510.1016/j.biopha.2018.02.065 ↗
21. 10.1002/anse.20210003510.1002/anse.202100035 ↗
22. 10.1038/srep4020310.1038/srep40203 ↗
23. 10.1016/j.ab.2017.12.02310.1016/j.ab.2017.12.023 ↗
24. 10.1016/j.biomaterials.2009.03.01210.1016/j.biomaterials.2009.03.012 ↗
25. 10.1039/d2ma00419d10.1039/d2ma00419d ↗
26. 10.1007/s11033-018-4467-210.1007/s11033-018-4467-2 ↗
27. 10.1007/s00216-021-03842-210.1007/s00216-021-03842-2 ↗
28. 10.1039/c6an01253a10.1039/c6an01253a ↗
29. 10.1039/c5an01995h10.1039/c5an01995h ↗
30. 10.1007/s10529-018-02641-710.1007/s10529-018-02641-7 ↗
31. 10.1088/1361-6528/ab804210.1088/1361-6528/ab8042 ↗
32. 10.1016/j.talanta.2017.01.05210.1016/j.talanta.2017.01.052 ↗
33. 10.1172/JCI918010.1172/JCI9180 ↗
34. 10.1159/00009608510.1159/000096085 ↗
35. 10.1089/oli.1.2000.10.6310.1089/oli.1.2000.10.63 ↗
36. 10.1002/jbm.b.3316210.1002/jbm.b.33162 ↗
37. 10.1002/bip.36031011110.1002/bip.360310111 ↗
38. 10.1158/1078-0432.CCR-06-169510.1158/1078-0432.CCR-06-1695 ↗
39. 10.1039/c9tb02457c10.1039/c9tb02457c ↗
40. 10.1021/am500678310.1021/am5006783 ↗
41. 10.1021/acs.analchem.1c0222810.1021/acs.analchem.1c02228 ↗
42. 10.1073/pnas.101619710810.1073/pnas.1016197108 ↗
43. 10.1002/adfm.20190978110.1002/adfm.201909781 ↗
44. 10.1002/anie.20200745110.1002/anie.202007451 ↗
45. 10.1038/s41416-023-02179-010.1038/s41416-023-02179-0 ↗
46. 10.1038/bjc.2011.29410.1038/bjc.2011.294 ↗
47. 10.1038/s41568-019-0180-210.1038/s41568-019-0180-2 ↗
48. 10.1016/j.molonc.2016.01.00710.1016/j.molonc.2016.01.007 ↗